The identification of patients with coronavirus disease 2019 and high risk of severe disease
is a challenge in routine care. We performed cell phenotypic, serum, and RNA sequencing …

Patients receiving anti-CD20 antibodies showed limited efficacy of a booster dose of
BNT162b2. Patients with lymphomas combine such immunotherapies with cytotoxic …

Background Mass drug administration (MDA) of praziquantel is one of the main control
measures against human schistosomiasis. Although there are claims for including pregnant …

Immunocompromised patients have a high risk of death from SARS-CoV-2 infection. Vaccination
with an mRNA vaccine may protect these patients against severe COVID-19. Several …

COVID-19 SARS-CoV-2 infection exhibits wide inter-individual clinical variability, from silent
infection to severe disease and death. The identification of high-risk patients is a continuing …

The authors declare that in their original article, there was an error in the calculation of the
library size for the normalization of some gene expression data. As a result, several figures, …

COVID-19 SARS-CoV-2 infection exhibits wide inter-individual clinical variability, from silent
infection to severe disease and death. The identification of high-risk patients is a continuing …

Specific methodological challenges exist in vaccine clinical trials, due principally to specificities
of vaccine development, clinical trial design, absence of validate correlate of protection, …

Background There is an urgent need of a new generation of vaccine that are able to enhance
protection against SARS-CoV-2 and related variants of concern (VOC) and emerging …

… To define these landmarks we first partition the body using a small subset of these
landmarks which we call primary points1. The primary points include right/left armpits, right/left …